Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 65, Number 4, August 23, 2005
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maciel, P.
Right arrow Articles by Santos, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maciel, P.
Right arrow Articles by Santos, M. M.
Related Collections
Right arrow All Movement Disorders
Right arrow Basal ganglia
Right arrow All Genetics
NEUROLOGY 2005;65:603-605
© 2005 American Academy of Neurology


Brief Communications

Neuroferritinopathy: Missense mutation in FTL causing early-onset bilateral pallidal involvement

P. Maciel, PhD, V. T. Cruz, MD, M. Constante, BSc, I. Iniesta, MD, M. C. Costa, BSc, S. Gallati, PhD, N. Sousa, MD, PhD, J. Sequeiros, MD, PhD, P. Coutinho, MD, PhD and M. M. Santos, PhD

From the Life and Health Sciences Research Institute (Drs. Maciel, Costa, and Sousa), School of Health Sciences, University of Minho, Braga, Portugal; UnIGENe (Drs. Maciel, Constante, Costa, Sequeiros, Coutinho, and Santos), IBMC, Department of Population Studies (Drs. Maciel and Sequeiros), ICBAS, University of Porto, Portugal; Hosp. S. Sebastião (Drs. Cruz, Iniesta, and Coutinho), Sta. Maria da Feira, Portugal; Department of Medicine (Drs. Constante and Santos), CHUM–Hôpital Notre-Dame, Université de Montreal, Québec, Canada; Department of Clinical Research and Department of Pediatrics (Dr. Gallati), University of Berne, Inselspital, Switzerland.

Address correspondence and reprint requests to Dr. Patrícia Maciel, Life and Health Sciences Research Institute, School of Health Sciences, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal; email: pmaciel{at}ecsaude.uminho.pt

The authors identified a missense mutation in the FTL gene (474G>A; A96T) in a 19-year-old man with parkinsonism, ataxia, corticospinal signs, mild nonprogressive cognitive deficit, and episodic psychosis. This mutation was also present in his asymptomatic mother and younger brother, who had abnormally low levels of ferritin in the serum. The patient and his mother displayed bilateral involvement of the pallidum.


Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the August 23 issue to find the title link for this article.

Research supported by FCT/FEDER (CBO/33485/99). M.C.C. and M.C. received FCT scholarships.

Disclosure: The authors report no conflicts of interest.

Received October 6, 2004. Accepted in final form February 24, 2005.




This article has been cited by other articles:


Home page
BloodHome page
T. V. Adamkiewicz, M. R. Abboud, C. Paley, N. Olivieri, M. Kirby-Allen, E. Vichinsky, J. F. Casella, O. A. Alvarez, J. C. Barredo, M. T. Lee, et al.
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury
Blood, November 19, 2009; 114(21): 4632 - 4638.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. Devos, P. J. Tchofo, I. Vuillaume, A. Destee, S. Batey, J. Burn, and P. F. Chinnery
Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation
Brain, June 1, 2009; 132(6): e109 - e109.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Baraibar, A. G. Barbeito, B. B. Muhoberac, and R. Vidal
Iron-mediated Aggregation and a Localized Structural Change Characterize Ferritin from a Mutant Light Chain Polypeptide That Causes Neurodegeneration
J. Biol. Chem., November 14, 2008; 283(46): 31679 - 31689.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Ohta, T. Nagasaka, K. Shindo, S. Toma, K. Nagasaka, K. Ohta, and Z. Shiozawa
NEUROFERRITINOPATHY IN A JAPANESE FAMILY WITH A DUPLICATION IN THE FERRITIN LIGHT CHAIN GENE
Neurology, April 15, 2008; 70(16_Part_2): 1493 - 1494.
[Full Text] [PDF]


Home page
BrainHome page
P. F. Chinnery, D. E. Crompton, D. Birchall, M. J. Jackson, A. Coulthard, A. Lombes, N. Quinn, A. Wills, N. Fletcher, J. P. Mottershead, et al.
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation
Brain, January 1, 2007; 130(1): 110 - 119.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.